LMR Partners’s Verona Pharma VRNA Stock Holding History

LMR Partners’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-48,500	Closed	-$2.25M	–	1651
2024 Q4	$2.25M	Buy	+48,500	New	+$1.82M	0.02%	570

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

LMR Partners's VRNA Position: Q4 2025 in Review

LMR Partners sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 143,200 shares — an estimated $15.3M sold.

LMR Partners first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $15.3M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

LMR Partners reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
LMR Partners sold 143,200 Verona Pharma shares in Q4 2025, an estimated $15.3M.
LMR Partners first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
LMR Partners's Verona Pharma position peaked at $15.3M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on LMR Partners's 13F filing for Q4 2025, filed 17 Feb 2026.